C. Garrison Fathman, MD
Associate Director of Autoimmunity
Dr. C. Garrison (Garry) Fathman, Founder and Past President of the Federation of Clinical Immunology Societies (FOCIS), Professor of Medicine in the Division of Immunology and Rheumatology at Stanford University School of Medicine, also serves as Director of the Center for Clinical Immunology at Stanford (CCIS).
Dr. Fathman’s contributions in the cellular and molecular immunology of CD4 T cells, and adoptive cellular gene therapy, have brought him international recognition. In particular, he is acclaimed for his establishment and exploitation of the technologies of antigen-specific T-cell cloning and adoptive cellular gene therapy, accomplishments that have facilitated a remarkable series of subsequent advances in understanding conventional immune response and provided insights into future therapy of autoimmune diseases.
As Founder and past President of FOCIS, Dr. Fathman led an extremely successful international effort to acknowledge and develop the field of clinical immunology. As Director of the CCIS, the Stanford-based FOCIS Center of Excellence, Dr. Fathman has initiated multi-disciplinary studies to generate novel approaches for the study of autoimmune diseases, including insulin-dependent diabetes mellitus, rheumatoid arthritis, and multiple sclerosis. He has also applied state-of-the-art technologies of genomics, proteomics, and bioinformatics to integrate approaches to diagnosis, prognosis, and therapy of these diseases.
After receiving his M.D. from Washington University in St. Louis, Dr. Fathman did his residency training at Dartmouth Affiliated Hospitals and completed a fellowship in immunology and rheumatology at Stanford University. He then spent four years doing bench research, first as a Clinical Associate at the Immunology Branch of the National Cancer Institute of the National Institutes of Health and subsequently as a Member of the Basel Institute of Immunology in Switzerland. He returned to the United States to join the faculty as Associate Professor of Immunology at the Mayo Clinic in 1977 and was recruited to Stanford School of Medicine as an Associate Professor in 1981.
Dr. Fathman is a member of many professional organizations, including the Association of American Physicians, American Society of Clinical Investigation (past Council member) and the American Association of Immunologists, and is the Past-President of the Clinical Immunology Society. He was associate editor of the prestigious Annual Review of Immunology for 25 years and serves on the editorial boards of numerous scientific journals. In addition, he has chaired a variety of national and international professional meetings and has written more than 250 articles on his research. Dr. Fathman has served as Chairman of two NIH study sections and currently serves on the governing council of TrialNet (a group of clinician scientists looking at the prevention and early treatment of type 1 diabetes) and as past Chairman of the autoimmune disease section of the Immune Tolerance Network.
ITI Internal